Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis MA Zocco, LZ Dal Verme, F Cremonini, AC Piscaglia, EC Nista, ... Alimentary pharmacology & therapeutics 23 (11), 1567-1574, 2006 | 660 | 2006 |
The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy A Armuzzi, F Cremonini, F Bartolozzi, F Canducci, M Candelli, V Ojetti, ... Alimentary pharmacology & therapeutics 15 (2), 163-169, 2001 | 482 | 2001 |
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study A Armuzzi, F Cremonini, V Ojetti, F Bartolozzi, F Canducci, M Candelli, ... Digestion 63 (1), 1-7, 2001 | 295 | 2001 |
Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial EC Nista, M Candelli, F Cremonini, IA Cazzato, MA Zocco, F Franceschi, ... Alimentary pharmacology & therapeutics 20 (10), 1181-1188, 2004 | 265 | 2004 |
Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study M Gabrielli, F Cremonini, G Fiore, G Addolorato, C Padalino, M Candelli, ... The American journal of gastroenterology 98 (3), 625-629, 2003 | 200 | 2003 |
Extradigestive manifestations of Helicobacter pylori gastric infection A Gasbarrini, F Franceschi, A Armuzzi, V Ojetti, M Candelli, ES Torre, ... Gut 45 (suppl 1), I9-I12, 1999 | 196 | 1999 |
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test L Miele, A Grieco, A Armuzzi, M Candelli, A Forgione, A Gasbarrini, ... Official journal of the American College of Gastroenterology| ACG 98 (10 …, 2003 | 175 | 2003 |
Predictive factors of renal involvement or relapsing disease in children with Henoch-Schönlein purpura D Rigante, M Candelli, G Federico, F Bartolozzi, MG Porri, A Stabile Rheumatology international 25, 45-48, 2005 | 163 | 2005 |
CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases F Franceschi, G Niccoli, G Ferrante, A Gasbarrini, A Baldi, M Candelli, ... Atherosclerosis 202 (2), 535-542, 2009 | 159 | 2009 |
Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores M Covino, C Sandroni, M Santoro, L Sabia, B Simeoni, MG Bocci, V Ojetti, ... Resuscitation 156, 84-91, 2020 | 158 | 2020 |
Clinical characteristics and prognostic factors in COVID‐19 patients aged≥ 80 years M Covino, G De Matteis, M Santoro, L Sabia, B Simeoni, M Candelli, ... Geriatrics & gerontology international 20 (7), 704-708, 2020 | 158 | 2020 |
Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases M Candelli, L Franza, G Pignataro, V Ojetti, M Covino, A Piccioni, ... International journal of molecular sciences 22 (12), 6242, 2021 | 157 | 2021 |
Breath testing for human liver function assessment A Armuzzi, M Candelli, MA Zocco, A Andreoli, A De Lorenzo, EC Nista, ... Alimentary pharmacology & therapeutics 16 (12), 1977-1996, 2002 | 156 | 2002 |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication EC Nista, M Candelli, MA Zocco, F Cremonini, V Ojetti, R Finizio, C Spada, ... Official journal of the American College of Gastroenterology| ACG 101 (9 …, 2006 | 153 | 2006 |
Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial EC Nista, M Candelli, F Cremonini, IA Cazzato, S Di Caro, M Gabrielli, ... Alimentary pharmacology & therapeutics 18 (6), 627-633, 2003 | 147 | 2003 |
Levofloxacin based regimens for the eradication of Helicobacter pylori S Di Caro, MA Zocco, F Cremonini, M Candelli, EC Nista, F Bartolozzi, ... European journal of gastroenterology & hepatology 14 (12), 1309-1312, 2002 | 129 | 2002 |
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 121 | 2020 |
Eradication of Helicobacter pylori Infection Improves Blood Pressure Values in Patients Affected by Hypertension A Migneco, V Ojetti, L Specchia, F Franceschi, M Candelli, M Mettimano, ... Helicobacter 8 (6), 585-589, 2003 | 119 | 2003 |
Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus A Gasbarrini, V Ojetti, D Pitocco, A De Luca, F Franceschi, M Candelli, ... European journal of gastroenterology & hepatology 10 (6), 469-472, 1998 | 117 | 1998 |
Non-COVID diseases during the pandemic: where have all other emergencies gone? V Ojetti, M Covino, M Brigida, C Petruzziello, A Saviano, A Migneco, ... Medicina 56 (10), 512, 2020 | 106 | 2020 |